Literature DB >> 26356312

Relationships Between Severity of Deformity and Impingement in Slipped Capital Femoral Epiphysis.

Carly E Jones1, Anthony P Cooper, Jonathan Doucette, Lawrence L Buchan, David R Wilson, Kishore Mulpuri, Agnes G d'Entremont.   

Abstract

BACKGROUND: In situ pinning, a low-risk treatment for slipped capital femoral epiphysis (SCFE), leaves the slipped femoral head in place and may reduce range of motion (ROM) and cause impingement. It is unclear when a more complex surgery should be considered, because the relationships between severity, slip stability, remodeling, impingement, and ROM are unknown. RESEARCH QUESTIONS: (1) Do more severe acute SCFE deformities (no bony remodeling) result in a greater loss of flexion ROM?(2) Does the presence or location of impingement on the pelvis vary with severity of acute SCFE deformity?
METHODS: We developed a 3D geometric model of acute SCFE deformity from 1 computed tomography scan of a normal adolescent hip. Ethics board approval was obtained from our institution. Bone models were created from the segmented pelvis, epiphysis, and subphyseal femur.In total, 3721 SCFE deformities were simulated by combining posterior and inferior slips in the axial and coronal planes, respectively. Southwick angles were estimated from a frog-leg lateral projection. Deformities were divided into mild (0 to 30 degrees), moderate (30 to 60 degrees), and severe (≥60 degrees) Southwick groups. Each joint was flexed in combination with internal/external rotation until contact occurred. A total of 121 ROM trials, with different degrees of internal/external rotation (0 to 90 degrees at 1.5-degree steps) were performed for each deformity.
RESULTS: In total, 3355 simulated SCFE deformities (363 could not be rotated out of impingement) were analyzed.Increasing slip severity reduced flexion ROM across the range of internal/external rotation. Contact occurred for most mild deformities, and for all moderate and severe deformities in at least 1 ROM trial. Impingement was observed mainly on the anterosuperior aspect of the acetabulum.
CONCLUSIONS: Increasing slip severity in acute SCFE reduced flexion and increased incidence of impingement, primarily occurring on the anterosuperior aspect of the acetabulum. The impingement patterns observed are consistent with damaged cartilage locations seen in clinical literature. CLINICAL RELEVANCE: In this experimental model, moderate and severe acute slips in SCFE lead to reduced ROM and impingement with the acetabulum. This suggests that in situ pinning may result in impingement of moderate and severe acute SCFE slips.

Entities:  

Mesh:

Year:  2017        PMID: 26356312     DOI: 10.1097/BPO.0000000000000641

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  4 in total

1.  Southwick angle measurements and SCFE slip severity classifications are affected by frog-lateral positioning.

Authors:  Carly E Jones; Anthony P Cooper; Jonathan Doucette; Lawrence L Buchan; David R Wilson; Kishore Mulpuri; Agnes G d'Entremont
Journal:  Skeletal Radiol       Date:  2017-08-24       Impact factor: 2.199

2.  Percutaneous pinning after prolonged skeletal traction with the hip in a flexed position for unstable slipped capital femoral epiphysis: A case series of 11 patients.

Authors:  Masaki Matsushita; Kenichi Mishima; Kohji Iwata; Tadashi Hattori; Naoki Ishiguro; Hiroshi Kitoh
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

3.  Hip arthroscopy following slipped capital femoral epiphysis fixation: chondral damage and labral tears findings.

Authors:  Javier Besomi; Valeria Escobar; Santiago Alvarez; Juanjose Valderrama; Jaime Lopez; Claudio Mella; Joaquin Lara; Claudio Meneses
Journal:  J Child Orthop       Date:  2021-02-01       Impact factor: 1.548

4.  The Effect of the Type of Screw Fixation Used in the Treatment of Slipped Capital Femoral Epiphysis.

Authors:  Tyler Rudolph; Katie Rooks; Haemish Crawford; Michael van der Merwe
Journal:  Adv Orthop       Date:  2022-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.